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Despite great advances in pediatric HIV care, rates and the extent of full disclosure of 
HIV status to infected children remain low especially in resource-constrained setting. The 
World Health Organisation recommends that, by the age of 10–12 years old, children 
should be made fully aware of their HIV-positive status. However, this awareness is often 
delayed until much later in their adolescence. Few studies have been conducted to 
investigate what influences caregivers’ decision-making process in this regard in low-in-
come settings. In this article, we present an analysis of care dyads of caregivers and 
HIV-positive young people in Kampala, Uganda, as part of the findings of a longitudinal 
qualitative study about young people’s adherence to antiretroviral therapy embedded in 
an international clinical trial (BREATHER). Repeat in-depth interviews were conducted 
with 26 young people living with HIV throughout the course of the trial, and once-off 
interviews with 16 of their caregivers were also carried out toward the end of the trial. In 
this article, we examine why and how caregivers decide to disclose a young person’s 
HIV status to them and explore their feelings and dilemmas toward disclosure, as well 
as how young people reacted and the influence it had on their relationships with and 
attitudes toward their caregivers. Caregivers feared the consequences of disclosing the 
young person’s positive status to them and disclosure commonly occurred hurriedly in 
response to a crisis, rather than as part of an anticipated and planned process. A key 
impediment to disclosure was that caregivers feared that disclosing would damage their 
relationships with the young people and commonly used this as a reason to continue 
to postpone disclosure. However, young people did not report prolonged feelings of 
blame or anger toward their caregivers about their own infection, but they did express 
frustration at the delay and obfuscation surrounding the disclosure process. Our findings 
can inform the ways in which mainstream HIV services support caregivers through the 
disclosure process. This includes providing positive encouragement to disclose fully and 
to be more confident in initiating and sustaining the timely process of disclosure.
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inTrODUcTiOn
More than two million young people below the age of 15 years are 
living with HIV globally with the vast majority in sub-Saharan 
Africa (1). Over the years, there have been remarkable improve-
ments in providing access to pediatric HIV treatment with 
antiretroviral therapy (ART), which has significantly reduced 
mortality rates (2) and enabled perinatally HIV-infected young 
people to live through adolescence and into young adulthood (3). 
Despite great advances in pediatric HIV care, however, rates and 
the extent of full disclosure of HIV status to HIV-positive young 
people remain low especially in resource-constrained settings (4).
Young people with perinatally acquired HIV often start ART 
in early childhood before knowing why they are taking it (5). The 
need to start treatment in childhood is acute, and at that time it 
may be accepted that the child will be told their HIV status and 
the reasons for their ART when they are older. The most recent 
global guidelines from the World Health Organisation (WHO) 
(6) on the disclosure to young people living with HIV recom-
mend that once children are of school-going age, and certainly 
by the age of 10–12 years old, they should be fully made aware 
of their condition and its consequences for them. However, this 
awareness is often delayed until much later in their adolescence 
(7–9).
In Uganda, it is estimated that of the 1.2 million people living 
with HIV, 13% are young people under 15 years (10). There are 
over 600,000 people in Uganda with access to ART and about 
43,000 of these are young people below the age of 15 years (11). 
However, a study on disclosure of HIV status to young people 
between 5 and 17  years in Southwestern Uganda showed that 
only 31% of the young people had been informed that they had 
HIV (12). Sociocultural norms are likely to influence disclosure 
conversations. For example, in Uganda discussing the routes of 
HIV transmission with young people as it relates to sexuality 
and the sexual behavior of their parents is problematic (13, 14). 
Despite this, few studies have been conducted to investigate what 
influences caregivers’ decision-making process in this regard in 
low-income settings.
In this article, through an analysis of care dyads of caregivers 
and HIV-positive young people, we examine why and how car-
egivers’ in Kampala, Uganda, decide to disclose a young person’s 
HIV status to them, as well as exploring their feelings and dilem-
mas toward disclosure.
The importance and challenges of 
Disclosure: current Views from the Field
Young people who have been appropriately informed of their 
illness early, exhibit better coping skills and fewer psychosocial 
problems (15). Being aware of their own HIV status as they 
transition into adolescence is crucial for young people living 
with HIV to assume some responsibility for managing their 
own treatment (16). Most available evidence shows an associa-
tion between disclosure and improved adherence to treatments 
(4, 17) although a recent qualitative synthesis suggests that the 
relationship between disclosure and the development of positive 
adherence habits is mixed (18). Beyond adherence, pediatric HIV 
disclosure is also positively associated with safer sex behaviors 
in adolescents, enabling them to actively participate in making 
decisions about their health and sexuality (19, 20).
The HIV disclosure literature conceptualize disclosure as a 
process and recommend that the disclosure responsibility lies 
with the caregivers/guardians of the child and that it should be 
tailored to a child’s cognitive development (21). These notions 
are reflected in the most recent WHO (22) and also the national 
guidelines from the Ministry of Health in Uganda (23). However, 
disclosure of perinatally acquired HIV is of course a complex 
and challenging process for caregivers and health-care workers. 
Indeed, research in African settings, including Uganda, has 
demonstrated that caregivers are reluctant to disclose and this 
is manifested in disclosure being postponed, treated as a one-off 
event and, when done, being partial and incomplete (8, 24, 25). 
Partial disclosure is the term used to describe situations in which 
young people are given some but not all the information about 
their illness or condition. They may be made aware of the fact that 
they have a health condition which requires them to take lifelong 
medication without being told that their “condition” is HIV (26).
Reasons for caregivers’ non-disclosure of young people’s HIV 
status cited in the literature include the pernicious stigma associ-
ated with HIV, which leads to caregivers being afraid that, once 
informed, young people may disclose their individual HIV status 
to others, placing them at risk of being discriminated against, for 
example, in schools (24). Caregivers’ postponement of disclosure 
may also stem from their worries about their child’s cognitive 
abilities and emotional readiness to receive the news of their 
(young people’s) own HIV-positive status (27). Fears that young 
people would be emotionally affected, cry, be sad, and give up 
on life following disclosure have all been identified as barriers 
to disclosure (28, 29). A study among Ugandan caregivers has 
shown that not disclosing to young people is seen as a form of 
protection from anticipated stress for the young people (9).
Caregivers may also have doubts as to the right timing for 
disclosure and about how much information about HIV is meant 
to be shared with young people (30). Indeed, several studies have 
reported on caregivers’ perceived lack of skills on how to disclose 
HIV infection to children (30, 31), for example, not knowing how 
to talk to the young people about HIV or how to explain mother 
to child transmission, which may lead them to engage in partial 
disclosure (32).
Furthermore, the inherited nature of the illness with perinatal 
acquisition means that there are direct risks for the caregivers 
and related household too once a young person’s status becomes 
known (24). Thus, as Muparamoto and Chiweshe (33) have 
shown, caregivers’ decision to disclose is affected by complex 
expectations in which they attempt to control the “strategic 
event” of disclosure to minimize the potential damage to their 
own identity and that of their child’s. However, another recent 
study in Uganda with young people aged 13–17 years has shown 
that they may exhibit considerable resilience in response to HIV 
disclosure (34), so there may be a disconnect between caregivers 
fears and young people’s response.
When disclosure does happen, there is significant evidence to 
suggest that caregivers decide to disclose on the instruction from 
health-care workers in a bid to support young people’s adherence 
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to HIV medication, while unintentional or forced disclosure 
has also been shown to be common (9, 35). Caregivers may also 
disclose as a result of young people’s persistent questioning about 
why they are taking medication, if they will ever stop and when 
they will get better (8).
Current global and local literature thus suggests that, despite 
policy guidance, caregivers hesitate to disclose HIV diagnosis to 
the young people. With this article, we aim to compare available 
literature and our own qualitative study findings from Uganda, to 
contribute to a better understanding of local dynamics pertaining 
to the Ugandan context and to illuminate caregivers as well as 
young people’s perspective on disclosure. We consider how these 
experiences impact on the disclosure process, how disclosure is 
received by young people themselves, and what can be done to 
improve support to caregivers to be more confident in initiating 
the timely process of disclosure. This will be important in the 
development of interventions to support caregivers and HIV-
positive young people through a process of fuller and ongoing 
disclosure.
MaTerials anD MeThODs
study setting and Population
This was a longitudinal qualitative study, involving young people 
perinatally infected with HIV and their caregivers, that was 
conducted between 2011 and 2016 at the Pediatric clinic of the 
Joint Clinical Research Centre (JCRC) in Kampala, Uganda. 
JCRC provides comprehensive HIV/AIDS care and management 
to about 2,000 HIV-infected young people and over 150,000 
adults. It was the first HIV/AIDS treatment center in Uganda 
to provide ART and is currently the country’s only reference 
center for third-line therapy. The study was embedded within a 
clinical trial (36) (BREATHER) which was testing the efficacy of 
a treatment interruption intervention, Short Cycle Therapy on 
efavirenz-based regimens (5  days on, 2  days off treatment) for 
young people (8–24 years) living with HIV (37).
Twenty-six young people were recruited purposively to par-
ticipate in repeat in-depth interviews, audio diaries, and focus 
group discussions. The topics covered in this article were not dis-
cussed in the focus group discussions or the audio diaries and so 
only the data from the in-depth interviews will be presented here. 
Purposive sampling was carried out to increase the likelihood 
of capturing various experiences. Young people were eligible to 
participate in the study if they were aged 10–24 years and had 
full knowledge of their HIV status for at least 6 months before 
being enrolled in the trial. The assumption is that 6 months after 
disclosure, through continued counseling and support, young 
people would have been more likely to have understood many of 
the implications of their HIV-positive status. A minimum age of 
10 years was selected to ensure that participants had the cognitive 
abilities to meet the broader aim of the study. Young people who 
met the criteria were approached for study participation together 
with their caregivers (for those below 18) within the waiting area 
of the clinic during their scheduled clinic visit. They were then 
taken to a private room in the clinic where they were given a 
detailed explanation of the study after which they gave written 
informed consent for participation. For those below the age of 
18 years, assent was obtained after their caregivers had provided 
written informed consent for them to participate in the study.
We understood consent to be a process which ran from initial 
recruitment through to dissemination, in which both caregivers 
and young people were involved. Study participants were given 
the opportunity to speak to a counselor, based in the clinic, at 
any time that they needed. The study provided additional funds 
to cover the counselor’s time, so that this resource would always 
be available throughout the study. This was in line with best 
research practice in this context, offering an integrated and sus-
tainable mechanism for support. All young people were offered 
the opportunity to speak to a counselor in case they needed to 
after they were interviewed, but none chose to do so. Also, each 
time a participant visited the clinic to engage in the qualitative 
study their transport costs were refunded, again in line with best 
local research practice.
Toward the end of the trial, all the 26 participants were asked 
to nominate a significant other, who was someone acting in a 
primary caring role for them, and that they would be comfortable 
for us to invite to also participate in the study. To be included 
in the study, the caregiver needed to be able to give all required 
information especially with regard to the child’s illness trajectory. 
To manage the volume of data, we had set a predetermined sample 
size of 16 caregivers. Once a young person had given their spe-
cific verbal consent, 16 caregivers were purposively selected and 
approached through their registered phone contacts at the clinic 
and invited to participate in an individual in-depth interview, and 
there were no refusals. The purposive sampling criteria ensured 
maximum variation within our sample for factors such as gender, 
socioeconomic background, and relationship to the child among 
others. A detailed explanation of the study including purpose, 
procedure, rights of volunteering participants, and assurance of 
confidentiality and anonymity were given to the caregivers. They 
provided informed consent.
The rationale for including the caregivers in the study was the 
recognition that they play a significant role in young people’s lives 
and influence their understanding and experience of living with 
HIV. We wanted to understand how caring for a young person 
living with HIV was understood and perceived, as well as learn 
more about whether and how the caregivers’ perceptions of HIV 
might shape their caring and relationship with the young person.
We present the findings from these care dyads, drawing on 
the 16 caregiver interviews and the in-depth interview data from 
the related young people. We deliberately do not present matched 
dyad data so that the caregivers and young people are not able to 
identify each other from the information we present here.
Data collection and analysis
Audio recorded, in-depth semi-structured interviews were con-
ducted using a topic guide, which was tailored to the circumstances 
of each individual. The topic guide covered the following key areas 
of investigation: managing children’s adherence; understandings 
of care; relationships within the household; and disclosing HIV 
status to young people. The guide was adjusted according to the 
circumstances that the caregiver disclosed, for example, whether 
they told us that they were themselves HIV positive. Interviews 
were conducted in English or the local language (Luganda) 
Table 1 | Themes and subthemes.
Theme subtheme
Reasons for caregivers’ 
reluctance to disclose
Fear of mentioning HIV
Fear of psychological damage to child
Fear of damaging child–caregiver relations
Concerns about stigma
Concerns about Discretion, HIV Stigma, and 
Discrimination
Not knowing how to talk about HIV
Factors that motivated 
disclosure
Adherence crisis/importance of drugs
Young people’s curiosity
Young people’s reactions Temporary feelings of shock. Frustration about 
delays in being disclosed to and partial nature 
of disclosure
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according to the participant’s preferred language of choice to 
ensure confidence in their responses. Each interview session 
lasted between 45 and 60 min. Stella Namukwaya, a social scien-
tist with extensive training and years of experience in qualitative 
research, conducted the interviews.
Recorded interviews were transcribed verbatim and translated 
where necessary by the first author. Discussions were held with 
other members of the research team (coauthors on this article) 
after each of the interviews to identify the emerging themes 
and to refine the interview guide to ensure issues arising were 
exhaustively explored.
Thematic analysis was carried out by all the four members 
of the research team (Stella Namukwaya, Sara Paparini, Janet 
Seeley, and Sarah Bernays). Transcripts were read and re-read to 
identify emerging patterns with specific focus on disclosure of 
HIV to young people. Themes were developed from participant’s 
responses and categorized as shown in Table 1. Content theme 
analysis was done to ensure that all relevant information was 
grouped and coded appropriately. Inter-rater reliability was very 
high (more than 80%) and the few discrepancies that arose were 
discussed and reconciled during regular weekly team meetings. 
Pseudonyms are used in this article to protect confidentiality.
ethical clearance
The study received institutional and national ethical approvals 
from the Uganda National Council for Science and Technology, 
National Drug Authority and the Joint Clinical Research Centre 
Institutional Review Board.
resUlTs
Participant characteristics
A total of 16 caregivers took part in this study and of those inter-
viewed, the majority were women (13 out of 16). Four of them 
were biological parents while the remaining were other relatives 
such as aunts, an uncle, stepmothers, and grandparents. Most car-
egivers were reportedly HIV negative. Of the 26 young people in 
our study, only 3 had primary male caregivers who brought them 
to the clinic and whom the young people nominated to be selected 
to participate in the study. All three were included in this study. 
This reflects common gender pattern of caregivers’ accompanying 
young people to this clinic. Discussion about the caregiver’s status 
only occurred when initiated by the caregiver themselves. We did 
not ask them directly about their HIV-positive status, however, 
all the caregivers talked about their status during the course of 
the interviews. Most caregivers were making a living on irregular, 
small scale business initiatives such as hairdressing and selling in 
markets. The majority had attained primary education while the 
rest completed secondary or vocational education.
All of the 26 young people who participated in the qualitative 
study had acquired HIV vertically and many had lost one or both 
parents. There were 14 girls and 12 boys in the study, between 
the ages of 10 and 24 years, and most of them were attending or 
had attained secondary school education. Further details of the 
sample can be found in our other publications from this study 
(7, 36, 38).
Although in the relevant guidelines responsibility to disclose 
HIV diagnosis is understood to lie with caregivers, we found that 
caregivers were very reluctant to do so. In this article, we first 
look at the reasons, which prompted caregivers to disclose and 
their concerns in doing so. We then present findings from the 
young people’s interviews to explore whether the concerns of 
the caregivers are borne out in young people’s narratives around 
finding out about their own HIV status.
reasons for caregivers’ reluctance to 
Disclose
Caregivers faced various difficulties in initiating disclosure 
conversations and talking to the young people about HIV and, 
where relevant, AIDS-related illness, and employed strategies to 
postpone disclosure. In the interviews, they provided many, often 
interlinked explanations for their decisions to delay conversations.
Fear of Mentioning HIV
Breaking news about HIV was something caregivers wished to 
avoid as long as possible. They did this by fabricating alternative 
explanations as to why their children were taking daily drugs. 
Almost any condition was considered preferable to HIV, so care-
givers commonly told the young people that they were taking 
medicines for kidney disease, malaria or tuberculosis, for exam-
ple. They did not necessarily presume that this was a strategy that 
would work indefinitely, but caregivers reported cycling through 
a range of alternative explanations:
In the beginning, she didn’t know what she was suf-
fering from, they (father) first told her that she had 
kidney disease, then later on that it was malaria (Kitty’s 
stepmother).
I would tell her that she had TB and even when we both 
started taking ART I told her that they were drugs for 
TB (Beth’s mother).
Fear of Emotional and Psychological Damage to the 
Child
When asked why they were avoiding disclosure, caregivers 
explained their reluctance was based on their anxiety about the 
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unknown potential psychological outcomes of disclosure for chil-
dren and young people. Caregivers’ reported being worried that 
disclosure might result in young people withdrawing from active 
social and educational engagements and interactions. They feared 
it would deprive them of their happiness and of the opportunity 
to live what the caregivers considered to constitute “a normal life.” 
As Tessa’s caregiver explained:
I was so scared of how she would react. I thought that 
she might have regrets, feel sad, start to isolate herself 
from people and feel like she has a problem (Tessa’s 
aunt).
Among our sample, the fear of the repercussions from dis-
closure was expressed more strongly by women than by men. 
Two of the male caregivers reported that even though they were 
concerned about the child’s emotional well-being they were more 
confident that the young people would not be grossly affected and 
would instead build resilience and understanding once their illness 
had been disclosed to them. However, male caregivers disclosed 
to the young people even later than the women. Men reported 
that they wanted to do this once the young people had reached 
the age of 13 years, and justified this by saying they were waiting 
for the young people to “mature” because then they would cope 
better with the information and not be damaged by it. However, 
with only three male participants in our study, any gender-related 
significance of this finding should not be overinterpreted.
I told (disclosed) Leah when she was 13 and I knew 
that it would be easy because in the end she would have 
understood (Leah’s father).
Concealment and delay strategies were additionally entwined 
with a desire to protect the young people from worrying about 
whether their caregivers or siblings were also HIV positive, and 
under any kind of threat:
We refused to tell them because we didn’t want to scare 
them because they would think that we also have HIV 
(Amy’s caregiver).
Fear of Damaging Child–Parent Relationships
For biological caregivers, disclosure carried with it more directly 
personal risks too. They were also concerned that young people 
would ask question as to how they had become HIV positive, 
which would lead to uncomfortable conversations about trans-
mission, the parents’ own experience of becoming HIV positive 
and questions of loss with regard to HIV-related deaths in the 
family. Mothers, in particular, were worried about being seen as 
“the source of infection” and blamed by the child. They were wor-
ried that disclosing would damage their relationship with their 
child, with young people being angry with them for “burdening” 
them with the virus.
For all caregivers, there was an anxiety that the young people 
had been failed by their parents by not being able to adequately 
protect them from acquiring HIV. In reality, as the caregivers 
were looking after young people aged 10–24 years old, there had 
been significant changes in provisions to prevent mother to child 
transmission since most of these young people had acquired 
HIV at birth, with many of them not able to benefit from current 
preventive treatments and practices.
Nearly all of the caregivers spoke about the risks that 
disclosure could potentially result in conflict and also put a 
strain on family relationships. This highlights the concern over 
the wave of revelations that disclosure to their child might 
precipitate.
I was worried and didn’t know how to tell her (Child) 
that I got HIV from her father, because that was what 
killed him (Jules’s mother).
Concerns about Discretion, HIV Stigma, and 
Discrimination
For both biological and non-biological caregivers, their desire to 
protect the young people from the potential for HIV stigma and 
discrimination further hindered disclosure. Caregivers did not 
trust that, once told, their child would be able to keep their own 
status a secret. They rationalized that by concealing this informa-
tion from the young people and thereby limiting the numbers of 
people who got to know about young people’s HIV status, they 
were protecting them from negative outcomes like being a source 
of gossip and being rejected by friends:
The disadvantage is that if you tell them, they will also 
tell someone else so people might start to gossip about 
the child … many people don’t know that he is sick 
(Gucci’s aunt).
This concern persisted despite the low levels of direct dis-
crimination that the caregivers had themselves experienced or 
witnessed. Only one of the caregivers reported being exposed to 
HIV-related discrimination. But they were all aware of stories 
about how people living with HIV had been subjected to dis-
crimination in the past and presumed that this prevailing attitude 
continued and could affect the young people.
The caregivers considered that adults were far better placed to 
deal with any negative fallout from their status becoming known. 
By contrast, they perceived that children were not competent to 
manage their own secrets. They stressed that stigma was a seri-
ous risk and felt that, if young people had to be subjected to it, 
the consequences would be too heavy for them to bear. Hence, 
even though they would agree that there might be benefits from 
disclosing one’s HIV status, such as support from peers, they were 
quick to emphasize that these only applied to adults living with 
HIV.
Delaying disclosure until young people were considered 
competent in managing information formed an important part 
of a more general strategy of maintaining silence about HIV. In 
most cases, caregivers had kept the HIV status of the child from 
other household members, and biological parents had often kept 
their own HIV status a secret from some or all of the rest of the 
household, too. So not talking to young people about HIV served 
also as an indirect way for caregivers to control information about 
themselves and their household.
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Not Knowing How to Talk about HIV (Inadequate 
Language and Understanding)
Caregivers also described feeling woefully underprepared to 
initiate and address disclosure conversations with the young 
people. They lacked confidence in how they should do it. They 
described not being certain about their biomedical knowledge of 
HIV and felt what they did know was insufficient to facilitate the 
disclosure process:
We used to think about it (disclosure) a lot and every 
time we tried to we would just postpone it (Max’s Aunt).
Although common overall, this was particularly an issue for 
non-biological caregivers who may have had little knowledge 
of HIV compared with biological caregivers that had been liv-
ing with HIV themselves or those who had close experience of 
their partners being affected. We found that biological caregivers 
who were themselves living with HIV had usually been able to 
disclose at home, while many of the non-biological caregivers 
had required the presence of counselors or other health-care staff 
because they did not know what to say.
This lack of confidence appeared to be even more problematic 
once the caregiver needed to move beyond naming the child’s 
condition. They described that their lack of knowledge and skills 
to manage conversations about HIV treatment, transmission, 
and prevention severely inhibited their capacity to engage in 
further discussions. An example many caregivers gave was not 
knowing how to explain changes in prevention of mother to child 
transmission (PMTCT) to young people. As reported in the inter-
views, caregivers’ explanations of transmission were commonly 
inaccurate and invariably brief, as exemplified by Lisa’s Aunt:
I explained to her that maybe it (HIV infection) was 
because of the c–section so that is how she got infected 
(Lisa’s Aunt).
Some caregivers also expressed concern about whether their 
child would be able to have sexual relationships and have children 
in the future. Although this was not an issue around the time of 
disclosure, but came up much later in adolescence, such concern 
also highlighted in caregivers’ interview accounts their limited 
understanding of PMTCT and HIV in general. It also fueled their 
concerns about their capacity to respond adequately to any of the 
young people’s questions upon being disclosed to and their anxi-
ety about the psychosocial impact of being told.
Some non-biological caregivers also lacked biographical 
knowledge pertaining to the child’s acquisition of HIV as they 
had taken on caring responsibilities after the death of the child’s 
parent. So, as they might not have been explicitly told how the 
child had acquired HIV this ambiguity added an additional layer 
of complexity. But it was also used to justify the partial approach 
to disclosure which deliberately avoided moving beyond naming 
their condition.
Factors That Motivated Disclosure
When caregivers did disclose, it very often tended to be because 
circumstances necessitated it. The decision was also never taken or 
planned for by the caregiver alone, but in response to the pressure 
of events. Thus, it was not always a decision based on what might 
be considered “age-appropriate” timing or the circumstances of 
the child.
Adherence Crisis and the Importance of Drugs
Supporting the child’s adherence to their treatment was the prior-
ity for many caregivers and a child struggling with their adher-
ence was the most common circumstance in which a caregiver 
disclosed to their child their HIV status. This was because health-
care workers frequently stressed to the caregivers that adherence 
would only improve if the child was made aware of their condi-
tion and thus more likely to understand how important the drugs 
were for their survival and well-being. Some explained that they 
would have had no intention of disclosing to young people until 
they were much older if they had been taking their medication 
well: “If he had been adhering to his drugs, I wouldn’t have been 
bothered with that” (Finn’s caregiver).
Of note, this approach highlights that many caregivers did not 
consider that disclosure was necessary beyond adherence and that 
children had an “independent” right to know their HIV status.
Focusing the disclosure conversation on the importance of 
drugs, however, was not only done because adherence was the 
key reason for disclosure in the first place. It was seen as a way 
for caregivers to comfort and give hope to the young people 
while revealing their status, to assure them that amidst their life-
threatening condition there is a known solution: taking the drugs. 
It appeared to give caregivers, and by extension young people, 
some control over what might happen in the future:
I comfort her and tell her that there are people on drugs 
who are now twenty years old or even thirty who are 
able to study and complete University (Leah’s dad).
Young People’s Curiosity
In some cases, disclosure was triggered by young people’s per-
sistent questions to their caregivers about why they were taking 
medicines every day, when or whether they would be able to stop 
taking them and whether they would ever be cured of whatever 
illness they had. Caregivers reported that as young people grew 
older (from the age of 10  years onward) they became increas-
ingly dissatisfied by the explanations that they had been given. In 
some cases, for example, when they were the only person in the 
household that they knew to be taking treatment, children had 
to ask questions for a considerable time to push to eventually be 
given the answer.
In the beginning, she didn’t know what she was suffer-
ing from […] she started asking questions as she grew 
older because she was wondering why she was not get-
ting better so they told her (Kitty’s stepmother).
She kept asking me why she was taking drugs when 
other children in the home were not (Tessa’s Aunt).
In households where pill taking was not such a guarded and 
secret activity, disclosure was also a response to questions from 
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other household members. Household members, especially the 
younger ones, became curious about why other young people 
were taking drugs every day unlike them or others in the home. 
Daisy’s uncle, for example, describes how both Daisy and her 
siblings were all asking questions about why she was taking 
drugs.
I eventually told her because she asked why she took the 
drugs alone (Daisy’s Uncle).
This curiosity put caregivers in a difficult position, and they 
were compelled to first disclose to the HIV-positive young 
people themselves, then also to the other household members. 
In their minds, having to tell so many people in quick succession 
dramatically loosened their control over the information and 
compounded the risks of unwanted disclosures. This highlights 
the tension and tussle in giving young people information about 
their own health, but also the prevailing reticence that imbued 
caregivers’ attitudes toward disclosing.
However, we found that one caregiver reported telling his child 
their HIV status directly the first time that she asked him about 
it. What is unusual about this case is that we were told that Leah 
had not asked her father any questions about why she was taking 
treatment until she was 13 years old, which is much later than the 
rest of the young people and caregivers in our study. By the time 
she asked, Leah’s father was confident that she understood what 
HIV was and what it might mean to be HIV positive. Her level of 
existing knowledge about the condition meant that answering her 
question directly by disclosing posed fewer risks to him than has 
been described by many of the other caregivers.
She first asked me what the drugs that she was taking 
every day were for so I told her that she was born with 
HIV (Leah’s dad).
Young People’s reactions to Disclosure
As we have described when caregivers disclosed this was nor-
mally limited to naming the condition and avoiding any further 
discussion of the implications of their illness. As most caregivers 
disclosed to facilitate improved adherence, the narrow function 
of disclosure was why they were taking medications. Discussions, 
even years later, often did not encompass what impact it may have 
on young people’s lives and how this could be managed and sup-
ported. While disclosure could give hope by emphasizing control 
through adherence, as shown the inherited nature of the perinatal 
acquisition of HIV meant that caregivers feared that disclosure 
could also disrupt and destroy relationships.
Critically, this was not borne out in our data. Over the course 
of the interviews when we asked the young people about their 
feelings toward being told they were HIV positive and whether 
and how this changed over time, they did not describe feeling 
resentment toward their parents.
Young people did not express anger or blame toward their 
parents. They had a fair grasp of the unintentional nature of the 
onward transmission and many understood that the prevention 
opportunities through treatment had not been available at the 
time that they had been born.
I didn’t blame them (parents) that much because even 
when they were alive I never saw them taking any drugs, 
but if they had been taking them, while we were not I 
would have blamed them for having kept silent, but they 
also didn’t know what was going on (Jack, 20 years old).
Most of the young people in the study could describe their 
“disclosure event,” recounting in considerable detail. They 
described their reaction as being terrified, worried, confused and 
intensely emotional. Yet they were not angry at their parents. In 
the few instances that they were, they described this as being a 
temporary reaction, which softened or vanished quickly.
When they (counselor) told me (disclosed) I got 
shocked but I didn’t take it as a very big issue (Amos, 
20  years old—was approximately 14  years old when 
disclosed to).
However, some felt aggrieved by their caregivers’ ambiguity, 
which met their initial questions and suspicions. They minded 
that they had been given partial or inaccurate information about 
their condition and their acquisition of HIV. They expressed frus-
tration that they were not able to have more candid conversations 
with their caregivers and have their questions answered. It was 
not the facts that bothered them, but the silence about them. It 
was this limited access to care and support that had a psychosocial 
impact. With no further follow-up discussions, their experience 
felt lonely and isolating.
And from the moment that I heard that (HIV positive 
status), my heart stopped beating for a moment and I 
started crying and tears flowed from my eyes without 
even knowing I was about to cry. I felt death was next, I 
felt lied to; I felt that I could not have a proper life (Nelly, 
18 years old).
DiscUssiOn
Encouraging appropriate and timely disclosure to young people 
about their own HIV is a central tenet in the care and manage-
ment of pediatric HIV (13). Disclosure of HIV diagnosis allows 
young people living with HIV to participate in making decisions 
they deem appropriate and to be aware of issues regarding their 
treatment, care, and sexuality. However, as we have illustrated in 
this article, as a result of the dilemmas that caregivers are faced 
with, the process was often condensed into a singular event, which 
took place either at home or at an HIV care facility in the presence 
of health-care workers. Our findings both echo current research 
(9) in this field and introduce new reflections from an analysis of 
caregivers and young people’s accounts about disclosure.
Our inclusion of care dyads and multiple interviews with 
young people has enabled us to provide valuable insight into 
the difference between caregivers’ expectations of the relational 
fallout of disclosure to young people and how it is experienced 
by young people themselves (34).
Although fear of the relational consequences of disclosing 
was a significant feature of caregivers’ accounts, no young 
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people described feeling prolonged anger toward their caregivers. 
Instead, what appeared to negatively impact their relationships 
from the young people’s perspectives were the caregivers’ silence, 
refusal to answer questions or obfuscation about the acquisition, 
nature, and consequences of their condition (39).
Jointly, our study and current literature (33) highlight that 
the anticipation of negative ramifications of disclosure caused 
significant anxieties for caregivers, which need further consid-
eration. Disclosure of HIV to children can be a murky process 
since it is about communicating about a condition that is lifelong, 
threatening, stigmatized and has no cure. For biological parents, 
it also involves bringing their own HIV-related life experiences 
into the picture in a way that may be unusual in their relationship 
with their children otherwise (40). A blunt and urgent approach 
to disclosure, for example, as a result of an adherence crisis, often 
leaves inadequate time for caregivers to feel prepared to deal with 
imagined or actual consequences (4, 27).
However, secrecy, concealment, and partial truths are part 
of the fabric of everyday relationships, and HIV disclosure is no 
exception (41). There is an ambiguity in caregivers’ silence that 
relates to their desire to protect young people from worry, and 
to shield them and their household from the possible impact of 
discrimination. At the same time, caregivers are trying to avoid 
addressing the question of transmission, and, as other studies 
have found (32, 33), fear being blamed and losing status in the 
eyes of their children. It also reflects the difficulty in engaging in 
conversations, for example, about the future, which have no easy 
answers (8).
It is certainly important to underscore how awareness and 
understanding about their HIV diagnosis helps young people 
develop their own ways to live with the condition, something we 
have repeatedly found in interviews with young people linked to 
this study (7, 36, 38) as well as in our other work (3, 8, 42, 43). 
However, our other studies also point to the problems created 
by disclosure as a medicalized moment driven by adherence (7, 
38) which does not take into consideration the social and the 
protective functions of silence as well as the tensions inherent to 
revelations and truths in the family.
Our findings illuminate the perspectives of caregivers as well 
as those of young people. A closer analysis of our data shows that 
pressuring caregivers into initiating conversation about HIV when 
they are not confident or ready may create long-term challenges 
for them and for young people because disclosure as a “forced” 
event will be kept to a minimum. While caregivers try to contain 
the potential damage of imparting information about HIV, this 
“bare minimum” approach leaves the young person wondering 
about the rest. Caregivers may be anxious to curtail the extent 
of disclosure, avoid follow-up questions, and restrict further 
discussion. The information about HIV may be imparted only 
as a matter of treatment adherence and onward infection. At the 
same time, this pivotal moment of partial revelation may signal to 
young people something about them is wrong, leaving little room 
for developing a helpful exchange about HIV as they grow up.
Therefore, the caregivers accounts in our study are an impor-
tant reminder that young people’s “right to know” should not be 
pitted against what caregivers’ perceive to be their “duty of care,” 
which includes but also extends beyond “improving adherence”: 
it is a balancing act between what they see as best for their children 
(those with and without HIV), themselves and their households. 
At the same time, caregivers’ desire to minimize harm to their 
relationship with their children by delaying disclosure might 
backfire if we take into consideration that young people discuss 
delays and silences on the matter of their HIV as frustrating and 
confusing omissions.
Based on our findings from this and other studies with young 
people, we would like to recommend that disclosure should be a 
supported process for all involved (6, 9, 44). Caregivers should be 
encouraged and supported to work toward the point of initiating 
a planned disclosure process, to avoid disclosure being conducted 
urgently in response to an adherence crisis. Even if disclosure is 
reactive, discussions with young people regarding the necessity 
of medication to sustain health need to be accompanied by a 
willingness to engage with young people in conversations about 
resilience and about the kind of present and future life they can 
envisage and imagine for themselves, to which medication is the 
means (38).
It is not sufficient to emphasize the necessity of disclosure to 
caregivers and expect them to be able to act without support. 
Short, supported disclosure courses should be offered within 
clinics by counselors to individual or groups of caregivers (45, 
46). These should include the following elements. First, caregiv-
ers need to be persuaded by the value in the child knowing about 
their own diagnosis, beyond managing or containing the par-
ticular events that they are dealing with at that immediate time. 
Second, caregivers need to be supported in feeling confident 
about their own knowledge about HIV, the circumstances of 
their child’s infection, and the realities of risks and opportunities 
for prevention of HIV. They also need to feel able to draw on the 
support of clinic staff in helping them to answer the range of 
questions that full disclosure may provoke. Third, and this is a 
point that has to date received relatively little emphasis, caregiv-
ers need reassurance that many young people, once they find out 
their status, do not harbor resentment toward their parents for 
their own infection. Fourth, caregivers and young people need 
support in finding strategies to manage potential discrimina-
tion. This could be delivered through follow-up meetings for 
groups of caregivers to offer and benefit from peer support and 
mentorship.
The relatively small study sample is a limitation for our study. 
It means that we should be cautious about interpreting gendered 
patterns in the different approaches of the caregivers. In addition, 
the data rely on the recall of many of our participants rather than 
exploring how disclosure was experienced in time. However, this 
approach provides valuable reflections and insight into the expe-
rience of disclosure over time and its effects on the relationships 
between caregivers and young people.
cOnclUsiOn
Our findings indicate that there is need to actively engage and 
equip parents and caregivers’ of young people living with HIV 
with adequate knowledge, information and skills which will 
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prepare them to initiate and facilitate discussions around disclo-
sure and HIV.
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